1/5
Healthcare finance intelligence for the next generation of analysts, investors, and scientists.
Deep dives, company analyses, educational primers, and open financial models from our global analyst team.
BioAsset is built on a simple belief: the best work happens when curious people are given real ownership. Our analysts aren’t siloed into rigid roles or buried under busywork. Every member of the team contributes meaningfully to research, writing, and editorial review, and no one’s contribution matters less than anyone else’s.
We sit at the intersection of life sciences and finance, and our team reflects that. Our analysts come from diverse academic backgrounds spanning biochemistry, economics, public health, and beyond, united by a genuine curiosity about how science creates value. That cross-disciplinary perspective is what makes our content sharper than what you’d find at a typical student org.
We also believe great output starts with genuine interest. Analysts have the flexibility to pursue the topics that excite them, whether that’s an FDA catalyst, a pipeline valuation, or a landmark deal reshaping the industry. When people care about what they’re researching, the quality speaks for itself.
If you want to do serious, professional-level work in healthcare finance alongside people who are just as driven and curious as you are, BioAsset is the place.
Growing team · Apply to join →
Conversations with leaders across biotech, healthcare finance, and the life sciences. Watch interview highlights on our Instagram here.
The most important developments in healthcare are driven by capital, science, and policy working together. BioAsset exists to make that intersection legible to the next generation of analysts, investors, and physicians.
We publish rigorous, accessible research. We build open financial models. We train student analysts to think across disciplines. And we do it all in public.
Whether you want to read, write, model, or just learn, there's a place for you.
We partner with professionals, students, and organizations operating at the intersection of life sciences and capital markets. If your work touches biotech, healthcare finance, or drug development, there's likely a way we can work together.
Whether you're an industry veteran, an aspiring analyst, or a student organization, we've built structured ways to collaborate.
Share your perspective with our audience of 7,000+ followers across biotech, pharma, and healthcare finance.
Format: 30–45 min recorded conversation, published as editorial content across our channels.
Ideal for: Biotech investors, sell-side analysts, pharma executives, academic researchers, and clinician-scientists.
Publish a biopharma or healthcare finance deep-dive with full author credit, reviewed by our editorial team.
Format: Written analysis piece — company breakdown, sector overview, or financial model walkthrough — edited and published under your name.
Ideal for: Students, graduate researchers, and early-career professionals building a public portfolio in healthcare finance.
Featured each month: One standout submission is selected as our Research Post of the Month, distributed across all BioAsset channels for maximum visibility.
We work with student groups, platforms, and organizations on cross-promotion, co-produced content, and joint events.
Format: Flexible — newsletter swaps, co-hosted panels, shared research projects, or event sponsorship.
Ideal for: University finance and biotech clubs, healthcare-focused media platforms, and life sciences organizations.
Tell us a bit about yourself and how you'd like to work together. We'll follow up within a week.
Reach out directly and we’ll find the right way to work together.
bioasset@bioasset.info
